Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/jspui/handle/10553/153719
Título: Modulating the Gut Microbiota via Rectal Ozone Insufflation in Gynecological Cancer Patients with Radiotherapy/Chemotherapy-Induced Pelvic Toxicity: A Proposed Clinical Study Protocol
Autores/as: Clavo Varas, Bernardino 
Cordoba-Lanus, Elizabeth
Martinez-Sanchez, Gregorio
Federico, Mario
Canovas-Molina, Angeles
Pinero, Jose E.
Vargas-Prado, Ana M.
Ramchandani, Avinash
Zajac, Marta
Ribeiro, Ivone
Navarro, Minerva
Jorge, Ignacio J.
Gonzalez-Martin, Jesus M.
Martin-Alfaro, Ruth
Fernandez-Tagarro, Maria
Diaz-Garrido, Juan A.
Lorenzo-Morales, Jacob
Rodríguez Esparragón, Francisco Javier 
Clasificación UNESCO: 32 Ciencias médicas
3201 Ciencias clínicas
320713 Oncología
320108 Ginecología
320112 Radioterapia, et al.
Palabras clave: Chemotherapy
Therapy
Ozone Therapy
Gut Microbiota
Gynecological Cancer, et al.
Fecha de publicación: 2025
Publicación seriada: Journal of Clinical Medicine 
Resumen: Background: Chronic pelvic toxicity induced by radiotherapy and/or chemotherapy (R/CIPT) is a debilitating sequela in gynecological cancer survivors, often refractory to conventional treatments and potentially linked to gut microbiota dysbiosis. Ozone therapy (OT), particularly rectal insufflation, demonstrates anti-inflammatory and redox-modulating effects through hormetic mechanisms (Nrf2 activation/NF-kappa B inhibition). We hypothesize that its clinical benefit is mediated, in part, by restoring gut microbial homeostasis. Objective: This manuscript proposes a clinical study to evaluate the impact of rectal OT on the gut microbiota of patients with gynecological cancers and chronic R/CIPT. Proposed Methods: A prospective, observational study of 38 patients is outlined: 19 with CTCAE v5.0 Grade >= 2 chronic R/CIPT receiving compassionate rectal OT (similar to 40 sessions over 4 months), and 19 matched controls without toxicity. Stool samples for 16S rRNA sequencing will be collected from the OT group pre- and post-intervention and once from controls. Primary endpoints are changes in microbiota composition/diversity and pelvic toxicity scores (CTCAE v5.0, EORTC QLQ-CX24). Secondary endpoints include quality of life (EORTC QLQ-C30, EQ-5D-5L), anxiety/depression (HADS), and serum inflammatory/oxidative stress biomarker analysis. Anticipated Results and Conclusion: This will be the first study to prospectively investigate whether rectal OT's effect correlates with a beneficial shift in the gut microbiota, specifically an increase in commensals (e.g., short-chain fatty acids producers) and a decrease in pathobionts. If successful, OT could be assessed as a novel, microbiota-targeting intervention for R/CIPT. The findings from this pilot study will provide the necessary groundwork for a future randomized controlled trial to definitively establish causality and efficacy.
URI: https://accedacris.ulpgc.es/jspui/handle/10553/153719
ISSN: 2077-0383
DOI: 10.3390/jcm14228015
Fuente: Journal Of Clinical Medicine [eISSN 2077-0383] ,v. 14 (22), (Noviembre 2025)
Colección:Artículos
Adobe PDF (530,24 kB)
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.